BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:S230815 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of S230815\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07227857-8920@assetmemo.bio
DTSTAMP:20261121T004544Z
DTSTART;VALUE=DATE:20280415
DTEND;VALUE=DATE:20280416
SUMMARY:S230815: Phase 1/2 readout est. (NCT07227857)
DESCRIPTION:S230815\, phase 1/2\, Epilepsy.\nStudy: A First-in-human Study 
 of S230815 in Pediatric Participants With KCNT1-related Developmental and 
 Epileptic Encephalopathy\nEstimated primary completion: 15 April 2028. Thi
 s is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it
  can move.\nDrug page: https://assetmemo.bio/drug/s230815#upcoming-events\
 nRegistry record: https://clinicaltrials.gov/study/NCT07227857
URL:https://assetmemo.bio/drug/s230815#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
